β-lactams are known to cause haematologic reactions. Cefoperazone is one such β-lactam that is commonly combined with a β-lactamase inhibitor, sulbactam. A review of the available literature suggests that cefoperazone can cause or precipitate haematologic reactions, including anaemia, leucopenia, thrombocytopenia and hypoprothrombinemia. Similarly, Escherichia coli (E. coli) is a commonly encountered organism associated with urinary tract infections and urosepsis, which can also present in a similar. This case report is a description of an elderly patient who harboured E. coli, and was also given cefoperazone-sulbactam, and later developed haematologic reactions.
|Number of pages||3|
|Journal||Research Journal of Pharmaceutical, Biological and Chemical Sciences|
|Publication status||Published - 01-07-2016|
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)
- Pharmacology, Toxicology and Pharmaceutics(all)